Centiva Capital’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-117,966
Closed -$130K 1517
2024
Q2
$130K Buy
+117,966
New +$130K ﹤0.01% 1342